Posted inSector Analysis
Measles Outbreak in Europe: Assessing Public Health Risks and Biotech Investment Opportunities
WHO reports a 47% rise in measles cases across Europe and Central Asia, driven by declining vaccination rates. This resurgence poses systemic risks to public health and economic stability while creating potential opportunities in the biotech and pharmaceutical sectors.
